Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 13:4.
doi: 10.3402/jmahp.v4.33177. eCollection 2016.

What makes a compliant Phase III and pre-launch patient advocacy strategy?

Nick Hicks  1 , Keith Allan  2 , Christoph Thalheim  3 , Paul Woods  4
Affiliations

What makes a compliant Phase III and pre-launch patient advocacy strategy?

Nick Hicks et al. J Mark Access Health Policy. .

Abstract

Background: A key task for the pharmaceutical industry is to understand the compliance implications of engaging with a patient advocacy group (PAG). This presents challenges for the industry to negotiate the ethical and reputational issues that can arise when working with a PAG.

Objective: To gain the views of pharmaceutical industry executives on future compliance challenges when working with PAGs.

Study design: We conducted two surveys among two sets of industry executives: one group focussed on market access roles and the other focussed on non-market access roles.

Results: Transparency was identified as the biggest challenge, followed by project rationale and then by project ownership.

Conclusion: We explore how this can be overcome and make recommendations on how best to work compliantly with PAGs.

Keywords: compliance; ethics; patient advisory group; pharmaceutical industry; reputation; transparency.

PubMed Disclaimer

Conflict of interest statement

and funding The authors have not received any funding or benefits from industry or elsewhere to conduct this study.

Similar articles

See all similar articles

References

    1. Francer J, Izquierdo JZ, Music T, Narsai K, Nikidis C, Simmonds H, et al. Ethical pharmaceutical promotion and communications worldwide: Codes and regulations. Philos Ethics Humanit Med. 2014;9:7. - PMC - PubMed
    1. Association of the British Pharmaceutical Industry. ABPI code of practice 2016. Available from: http://www.pmcpa.org.uk/thecode/Documents/Code of Practice 2016.pdf.
    1. International Federation of Pharmaceutical Manufacturers and Associations. IFPMA code of practice. Available from: http://www.ifpma.org. - PubMed
    1. EFPIA code on the relationship between the pharmaceutical industry and patient organisations. 2011. Available from: http://transparency.efpia.eu/uploads/Modules/Documents/code_po2011.pdf.
    1. Transparency International. Corruption in the pharmaceutical industry. 2016. Available from: http://www.transparency.org.uk/publications/corruption-in-the-pharmaceut...

LinkOut - more resources